BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kobori T, Tanaka C, Tameishi M, Urashima Y, Ito T, Obata T. Role of Ezrin/Radixin/Moesin in the Surface Localization of Programmed Cell Death Ligand-1 in Human Colon Adenocarcinoma LS180 Cells. Pharmaceuticals (Basel) 2021;14:864. [PMID: 34577564 DOI: 10.3390/ph14090864] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Gagliardi A, Francescato G, Ferrero G, Birolo G, Tarallo S, Francavilla A, Piaggeschi G, Di Battista C, Gallo G, Realis Luc A, Sacerdote C, Matullo G, Vineis P, Naccarati A, Pardini B. The 8q24 region hosts miRNAs altered in biospecimens of colorectal and bladder cancer patients. Cancer Medicine 2022. [DOI: 10.1002/cam4.5375] [Reference Citation Analysis]
2 Doukuni R, Kobori T, Tanaka C, Tameishi M, Urashima Y, Ito T, Obata T. Moesin Serves as Scaffold Protein for PD-L1 in Human Uterine Cervical Squamous Carcinoma Cells. JCM 2022;11:3830. [DOI: 10.3390/jcm11133830] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tameishi M, Ishikawa H, Tanaka C, Kobori T, Urashima Y, Ito T, Obata T. Ezrin Contributes to the Plasma Membrane Expression of PD-L1 in A2780 Cells. J Clin Med 2022;11:2457. [PMID: 35566582 DOI: 10.3390/jcm11092457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Tanaka C, Kobori T, Okada R, Doukuni R, Tameishi M, Urashima Y, Ito T, Takagaki N, Obata T. Ezrin Regulates the Cell Surface Localization of PD-L1 in HEC-151 Cells. JCM 2022;11:2226. [DOI: 10.3390/jcm11082226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Kobori T, Doukuni R, Ishikawa H, Ito Y, Okada R, Tanaka C, Tameishi M, Urashima Y, Ito T, Obata T. Ezrin and Radixin Differentially Modulate Cell Surface Expression of Programmed Death Ligand-1 in Human Pancreatic Ductal Adenocarcinoma KP-2 Cells. Immuno 2022;2:68-84. [DOI: 10.3390/immuno2010006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]